Clinical trial
Serum-Ascites Albumin Gradient Analysis in Cancer Patients in Palliative Care
NCT03463655 is registered in ClinicalTrials.gov with Institut Paoli-Calmettes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Serum-Ascites Albumin Gradient Analysis in Cancer Patients in Palliative Care
- Lead sponsor
- Institut Paoli-Calmettes
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 21, 2017
- Completion date
- April 30, 2018
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
solid cancer in a palliative situation with ascites